Results 241 to 250 of about 41,600 (260)

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Journal of the American Academy of Dermatology, 2018
Simone Cazzaniga, Marie Aleth Richard, René Valero   +2 more
exaly  

Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions

Circulation, 2012
Akihiro Hirashiki, Toyoaki Murohara, Yasuko K Bando   +2 more
exaly  

Substance P Increases Sympathetic Activity During Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition

Hypertension, 2014
Nancy Brown, , Chang Yu
exaly  

Dipeptidyl peptidase‐4 inhibitors and cardiovascular safety

Medical Journal of Australia, 2014
openaire   +2 more sources

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

Diabetes, 2011
Jürgen Eckel, Henrike Sell, Margriet Ouwens   +2 more
exaly  

The Unique Properties of Dipeptidyl-peptidase IV (DPP IV I CD26) and the Therapeutic Potential of DPP IV Inhibitors

Current Medicinal Chemistry, 1999
Koen Augustyns, F Goossens, C Durinx
exaly  

Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials

International Journal of Cardiology, 2016
, Nathorn Chaiyakunapruk, Surakit Nathisuwan   +2 more
exaly  

Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials

Current Medical Research and Opinion, 2011
Matteo Monami, Edoardo Mannucci
exaly  

Novel Therapeutic Role for Dipeptidyl Peptidase III in the Treatment of Hypertension

Hypertension, 2016
Hisakazu Ogita, Shinji Kume, Akio Shimizu   +2 more
exaly  

Synthesis and evaluation of pyrazolidine derivatives as dipeptidyl peptidase IV (DP-IV) inhibitors

Bioorganic and Medicinal Chemistry Letters, 2005
Jin Hee Ahn, Hyae Gyeong Cheon, Kwang Rok Kim   +2 more
exaly